Co-Medication of Statins with Contraindicated Drugs

BACKGROUND: The concomitant use of cytochrome P450 3A4 (CYP3A4) metabolized statins (simvastatin, lovastatin, and atorvastatin) with CYP3A4 inhibitors has been shown to increase the rate of adverse events. OBJECTIVE: This study was performed to describe the co-medication prevalence of CYP3A4-metabol...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Bo Ram, Seong, Jong-Mi, Choi, Nam-Kyong, Shin, Ju-Young, Lee, Joongyub, Kim, Ye-Jee, Kim, Mi-Sook, Park, Soyoung, Song, Hong Ji, Park, Byung-Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416887/
https://www.ncbi.nlm.nih.gov/pubmed/25932626
http://dx.doi.org/10.1371/journal.pone.0125180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416887/
https://www.ncbi.nlm.nih.gov/pubmed/25932626
http://dx.doi.org/10.1371/journal.pone.0125180

Ejemplares similares